TAmiRNA
TAmiRNA is a biotech company specializing in the discovery and validation of microRNA biomarkers for precision medicine, focusing on age-associated diseases such as osteoporosis, cardiovascular and liver diseases. The company develops diagnostic algorithms based on microRNA signatures combined with clinical parameters to improve patient outcomes and personalized diagnostics. TAmiRNA offers RNA biomarker discovery, validation, and development services including targeted and untargeted RNA analysis, microRNA disease panels, and in-house analysis services for their IVD and RUO kits. They collaborate with academic and industry partners and have over 11 years of expertise in RNA biomarker development, positioning themselves as innovators in transcriptomics and biomarker-driven diagnostics.
TAmiRNA
TAmiRNA is a biotech company specializing in the discovery and validation of microRNA biomarkers for precision medicine, focusing on age-associated diseases such as osteoporosis, cardiovascular and liver diseases. The company develops diagnostic algorithms based on microRNA signatures combined with clinical parameters to improve patient outcomes and personalized diagnostics. TAmiRNA offers RNA biomarker discovery, validation, and development services including targeted and untargeted RNA analysis, microRNA disease panels, and in-house analysis services for their IVD and RUO kits. They collaborate with academic and industry partners and have over 11 years of expertise in RNA biomarker development, positioning themselves as innovators in transcriptomics and biomarker-driven diagnostics.
TL;DR
Sector: Biotech — microRNA / RNA biomarker discovery and diagnostics
Headquarters: Vienna, Austria
Founded: 2013
Employees: 16
Products / Services: microRNA diagnostic panels, RNA biomarker discovery/validation, CRO/transcriptomics services
Company Overview
Problem Domain
Biomarker-driven precision diagnostics for age-associated and complex diseases; translational RNA biomarker discovery and validation.
Founded
2013
Industry
Biotechnology / Molecular diagnostics
Tech Stack
Funding Track Record
60000.00
Grant funding recorded; company participates in collaborative grant-funded projects (e.g., Eurostars/EUREKA initiatives).
Investor Signal
“grant-supported, including EASME / Eurostars-related funding”